ijerph International Journal of Environmental Research and Public Health Int. J. Environ. Res. Public Health International journal of environmental research and public health 1660-4601 MDPI 10.3390/ijerph9030698 ijerph-09-00698 Review Biomarker Genes for Detecting Estrogenic Activity of Endocrine Disruptors via Estrogen Receptors Jung Eui-Man An Beum-Soo Yang Hyun Choi Kyung-Chul Jeung Eui-Bae * Laboratory of Veterinary Biochemistry and Molecular Biology, College of Veterinary Medicine, Chungbuk National University, Cheongju, Chungbuk 361-763, Korea; Email: jemman@hanmail.net (E.M.J.); vetterang@hotmail.com (B.S.A.); anpoong@naver.com (H.Y.); kchoi@chungbuk.ac.kr (K.C.C.) Author to whom correspondence should be addressed; Email: ebjeung@chungbuk.ac.kr; Tel.: +82-43-261-2397; Fax: +82-43-267-3150. 24 02 2012 03 2012 9 3 698 711 26 12 2011 02 02 2012 20 02 2012 © 2012 by the authors; licensee MDPI, Basel, Switzerland. 2012

This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).

Endocrine disruptors (EDs) are compounds used in various industrial products, drugs, and cosmetics. They can be found in the environment and disturb the endocrine and reproductive systems, resulting in adverse effects to humans and wildlife such as birth defects and developmental disorders. Since several EDs have a structure similar to that of endogenous steroid hormones such as estrogens, they intend to have an affinity for steroid hormone receptors and alter hormone-mediated metabolism by binding to these receptors. EDs are therefore a global concern and assays should be developed to efficiently determine whether these compounds are detrimental to biological systems. Diverse experimental methods may help determine the endocrine disrupting potential of EDs and evaluate the adverse effects of a single and/or combination of these reagents. Currently, biomarkers have been employed to objectively measure EDs potency and understand the underlying mechanisms. Further studies are required to develop ideal screening methods and biomarkers to determine EDs potency at environmentally relevant concentrations. In this review, we describe the biomarkers for estrogenicity of EDs identified both in vitro and in vivo, and introduce a biomarker, cabindin-D9k (CaBP-9k), that may be used to assess estrogenic activity of EDs.

 endocrine disruptors estrogen activity biomarker calbindin-D9k 1. Introduction

Endocrine disruptors (EDs) are environmental chemicals that disrupt the endocrine system of wildlife and humans. Studies performed in the 1930s showed that a number of synthetic chemicals have estrogenic properties, and the feminizing effect of the pesticide dichlorodiphenyltrichloroethane (DDT) was demonstrated in roosters in the 1950s [1,2]. Hormonally active chemicals, (i.e., diethylstilbestrol or DES) were widely used to prevent abortions until 1971; however, vaginal clear cell carcinogenesis was observed in young women due to use of synthetic estrogen during pregnancy [3]. Furthermore, female offspring from women who were exposed to DES had an increased risk of reproductive and immunologic abnormalities, and male offspring were at risk for genital anomalies and abnormal spermatogenesis [4,5]. It was also reported that EDs potentially cause fetal pathophysiology, abnormal maturation of the brain, learning disabilities, disorders associated with attention, motivation, emotion and cognitive development. In addition, reduction of sperm count and prostate enlargement in males; ovarian and uterine dysfunctions in females have been reported [6,7]. These findings indicate that hormonal disruption caused by EDs in animals and humans results in serious adverse effects.

EDs are widely found in drugs, pesticides, and compounds used for manufacturing plastics (see Table 1). Most EDs have a structure similar to that of endogenous steroid hormones and primarily act through nuclear hormone receptors including estrogen receptors (ERs), androgen receptors (ARs), and thyroid receptors (TRs) [8]. Having a structure similar to that of hormones permits EDs to exert abnormal effects that disrupt endocrine systems through diverse pathways including binding to hormone receptors, mimicking hormone action, and blocking the action of hormones [9,10,11]. Estrogen (E2) is hormone essential for the development of reproductive organs, bone, liver, and the cardiovascular system, and plays an important role in many physiological processes [12]. Diverse types of EDs have been shown to have estrogenic activity because of high binding affinity for ERs. ERs are steroid hormone nuclear receptors and act as ligand-activated transcription factors. ERs have two isoforms, ER-α and ER-β, which can bind a wide variety of EDs and activate the transcription of estrogen-responsive genes [13,14]. However, there are no standard methods to determine whether certain EDs have an estrogenic activity or not. In this review, we discuss diverse methods to evaluate EDs and discuss the use of CaBP-9k as a biomarker for identifying estrogenic EDs.

ijerph-09-00698-t001_Table 1

List of estrogenic EDs.

Chemical Class EDs References
Industrial byproducts Polychlorinated biphenyls (PCBs)
Polybrominated biphenyls (PBBs)
Dioxins [15,16]
Plastics Bisphenol A (BPA) [17,18]
Plasticizers Phthalates [19,20]
Pesticides Methoxychlor
Chlorpyrifos
Dichlorodiphenyltrichloroethane [21,22]
Fungicides Vinclozolin [23,24]
Pharmaceutical agents DES [3,5]
Biodegradation products Octyl-phenol (OP)
Nonylphenol (NP) [25,26]
Phytoestrogens Genistein
Coumestrol [24,27,28]
2. Biomarkers for Measuring the Estrogenic Effect of EDs 2.1. Vitellogenin

Vitellogenin (VTG) is an egg yolk precursor protein and is normally produced by liver cells of female fish in response to E2 secreted by the pituitary gland [29]. It is released into the blood where it circulates until it reached the ovaries and promotes oocyte development. Male fish also carry the VTG gene, although VTG protein is normally not expressed because the circulation levels of E2 are extremely low in male blood plasma [30]. However, males still have the capability to express VTG, and male fish are known to produce the protein under the influence of estrogenic EDs [30,31,32]. E2, NP, and OP all induce the expression of VTG in male fish in a dose-dependent manner [33,34], suggesting that the VTG gene in male fish can be used as a biomarker for evaluating the effects of EDs [35,36,37].

2.2. Complement C3 and Ornithine Decarboxylase

The uterus is a general target organ for estrogen-mediated metabolism. A uterotrophic bioassay is widely used to measure increased uterine wet weight after EDs treatment [38]. However, this assay does not evaluate effects other than those associated with the estrogenic activity of EDs which could lead increased uterine weight via unknown pathways. In the past few years, several genes regulated in the uterus have been identified and used as marker genes to assess the estrogenicity of EDs. For example, genes for the gap junction connexin, such as connexin 26 and connexin 43, the plasma glycoprotein clusterin, and complement C3 were shown to be highly regulated by E2 in rat endometrium [39,40,41].

Complement C3, simply called C3, is a protein involved in the immune system which plays a central role in activating complement pathways and promotes innate immunity [42]. In adult female mice, C3 is exclusively expressed in the uterus. E2 administration to immature or ovariectomized mice significantly increases C3 mRNA levels as well as immunoreactivity in the endometrium, indicating that the synthesis of this protein is regulated by E2 in mouse endometrium [43]. Phyto- and xenogestogens have been found to induce C3 expression in endometrium, and the sensitive parameter of C3 is highly suited to investigate the biological potential of natural and synthetic estrogens [39].

The enzyme ornithine decarboxylase catalyzes the decarboxylation of ornithine (a product of the urea cycle) to form putrescine, which is the committed step in polyamine synthesis [44]. The rapid growth and differentiation of uterus are concomitant with increased expression of the ornithine decarboxylase gene. Recent studies have shown that expression of ornithine decarboxylase gene in the uterus is augmented by EDs [45,46,47,48]. These estrogen-sensitive genes have therefore been used as markers for evaluating the estrogenic potential of EDs in the uterus

 2.3. pS2 and Mucin 1

pS2 is a low molecular weight protein containing 60 amino acid. E2 and estrogenic compounds stimulate the expression of pS2 which was first observed in the MCF-7 breast cancer cell line into which the pS2 gene has been cloned [49]. pS2 mRNA production can be rapidly induced by E2 in certain breast cancers, but not in normal breast tissue nor in any other human cell lines. Therefore, pS2 mRNA expression in MCF-7 cells is an ideal model for studying the effects of estrogenic compounds [49,50,51].

Cell surface mucins are a family of highly glycosylated glycoproteins found in the apical cell membranes of epithelial cells from the mammary gland, salivary gland, respiratory tract, digestive tract, uterus, and testis [52,53]. Mucin1 (MUC1), a mucin and well-known marker of breast cancer, is an extended rod-like molecule which protrudes above the cell surface of epithelial cells [54]. The MUC1 promoter region has half of an estrogen response element (ERE) and is regulated by E2. Therefore, MUC1 is known to be a direct E2 target gene due to specific ER binding in MCF-7 cells [55]. EDs, including NP, have been reported to induce the expression of pS2 and MUC1 in MCF-7 breast cancer cells [54].

2.4. Progesterone Receptor

The progesterone receptor (PR) is an intracellular steroid receptor that specifically binds to progesterone and is involved in a wide variety of physiological functions including the control of embryonic development, cell differentiation, and homeostasis [56,57,58]. The PR gene is a known target of E2 in certain cell lines including MCF-7 and GH3 cells that express ERs [59,60]. Recent studies have observed EDs-induced expression of PRs in GH3 rat pituitary cells. Several parabens and E2 significantly increased PR expression in these cells [60], demonstrating that PR levels may be augmented by EDs through an ER-mediated pathway in GH3 cells [61,62]. By measuring the expression levels of VTG, Complement C3, ornithine decarboxylase, pS2, MUC1 and PR genes, EDs estrogenicity can be efficiently evaluated in a cost- and time-effective manner.

3. <italic>CaBP-9k</italic> Gene Expression as a Biomarker for Assessing the Effects of EDs 3.1. Introduction of the CaBP-9k Gene

Calbindin-D9k (CaBP-9k) is a 9-kDa cytosolic protein and a member of the S100 family of calcium-binding proteins that includes calmodulin, paravalbumin, troponin C, and calbindin-D28k. These calcium-binding proteins were recently classified into different sub-families as they differ in the number of calcium-binding EF-hand sites [63,64]. CaBP-9k has two calcium-binding domains that have high affinities for calcium. The CaBP-9k gene is localized on the X chromosome and consists of three exons interrupted by two introns [65,66]. The CaBP-9k protein is composed of 79 amino acids. The C-terminal site (amino acids 54–65) is a normal EF-hand similar to that found in other proteins of the S100 family while the N-terminal site (amino acids 14–27) has a unique structure containing different amino acids. However, N-terminal site have not disrupted the calcium binding ability of CaBP-9k [67].

3.2. Regulation of CaBP-9k Gene Expression

CaBP-9k is an intracellular factor primarily known as a vitamin D-dependent calcium-binding protein found in the cytoplasm of intestinal cells [68,69]. CaBP-9k expression has been reported in intestine, kidneys, bone, lung, placenta, pituitary gland, and uterus [70]. Duodenal and renal CaBP-9k are involved in calcium absorption and re-absorption; its expression is regulated by 1,25-dihydroxyvitamin D3 [71,72]. Duodenal CaBP-9k is mainly expressed in enterocytes of the duodenum in rodents and is involved in intestinal calcium absorption [73]. Additionally, the level of CaBP-9k mRNA is thought to be a marker of small intestine differentiation [74,75]. Renal CaBP-9k plays a role in calcium re-absorption in the kidney, which is important for maintaining calcium homeostasis in the body. Ionized and calcium enters the glomerular filtrate by convection and is re-absorbed by the renal tubules [72]. Renal CaBP-9k is expressed at the site of calcium re-absorption and localized in the distal convoluted tubules in rodents [76,77].

The regulation of CaBP-9k expression in other tissues other than duodenum and kidney is known to be accomplished through different mechanisms. For instance, uterine CaBP-9k is not under the control of 1,25-dihydroxyvitamin D3 despite the presence of 1,25-dihydroxyvitamin D3 receptors [78]. Uterine CaBP-9k is expressed mainly in the endometrial stroma and myometrium in non-pregnant rodents and regulated by sex steroid hormones [79,80]. An estrogen response element (ERE) in the CaBP-9k promoter mediates transcriptional regulation of CaBP-9k in the presence of E2 in rat uterus [81]. On the other hand, a progesterone response element (PRE) in the CaBP-9k promoter is responsible for responsiveness to progesterone (P4) in mouse uterus [82]. Interestingly, uterine CaBP-9k is up-regulated by E2 and down-regulated by P4 during the estrous cycle in rat uterus [83,84], while it has been shown to be decreased by E2 in mouse uterus [85,86,87].

 3.3. <italic>In Vivo</italic> Evaluation of Estrogenic Activity of EDs Using the CaBP-9k Gene

Recently, CaBP-9k was suggested to be a novel biomarker for evaluating EDs activity [88,89]. CaBP-9k expression levels increased by exposure to EDs are considered to be effective tools for screening estrogenic compounds in in vivo models. Recent studies demonstrated that estrogenic compounds significantly increase the expression of uterine CaBP-9k in rats [78]. An et al. showed that E2, OP, NP, and BPA increased uterine CaBP-9k gene expression in rats. Furthermore, these estrogenic compounds also significantly increase uterine weight in rats [84,89]. Estrogenic compounds, which form a class of EDs that includes diethylstilbestrol [90], tetrabromodiphenyl ether [91], phthalates [92] genistein [93], and parabens [94], strongly induce uterine CaBP-9k mRNA and protein expression in the uterus of rats. Moreover, the ER antagonist ICI 182,780 prevents increased expression of uterine CaBP-9k when co-administered with estrogenic compounds. It has been confirmed that ER-mediated signaling is involved in the induction of CaBP-9k gene expression by estrogenic compounds [95]. These findings suggest that the CaBP-9k gene is a useful biomarker gene for assessing the estrogenic potential of EDs.

The ability of CaBP-9k for evaluating EDs in an in vivo system is summarized in Table 2. Triclosan, tetrabromodiphenyl ether 47 (BDE47), and genistein at concentrations less than 50 mg/kg have been found to have regulatory effects on uterine CaBP-9k expression [91,93]. Triclosan at a dose of 37.5 mg/kg up-regulates uterine CaBP-9k expression in an immature rat model [96]. Genistein has similar potential with triclosan at dose of 40 mg/kg. Treatment with BDE47 (50 mg/kg) led a significant increase in uterine CaBP-9k as determined by RT-PCR. OP, NP, and BPA (600 mg/kg) induce uterine CaBP-9k expression at in the rat; however, lower concentrations (100 to 250 mg/kg) of these compounds had a more prominent effect in mice [84]. Methoxychlor (250 mg/kg) was reported to have a moderate effect on CaBP-9k expression in rat uterus [97]. Butyl benzyl phthalate (BBP), dicyclohexyl phthalate (DCHP), 2-ethylhexyl phthalate (DEHP), di-n-butyl phthalate (DBP), and diethyl phthalate (DEP) do not have any significant estrogenic effects on CaBP-9k gene expression in rat uterus [92]. Changes in CaBP-9k expression for assessing EDs activity are sufficient when compared to other biomarkers. For example, C3, a well-known biomarker for measuring EDs effects, shows a level of sensitivity similar to that of CaBP-9k at a concentration in the presence of OP and BPA (200 mg/kg) [40].

ijerph-09-00698-t002_Table 2

Expression of uterine CaBP-9k in in vivo system by different EDs concentrations.

Endocrine disruptors Doses (mg/kg) Animal Route Method Reference
Triclosan 37.5 rat Oral q-PCR/western [96]
Genistein 40 rat S.C injection Western [93]
Tetrabromodiphenyl ether 47 50 rat S.C injection RT-PCR [91]
Octyl phenol 100/600 mouse/rat S.C injection Western [84]
Methoxychlor 200 rat Oral Northern [97]
Nonyl phenol 250/600 mouse/rat S.C injection Western [84]
Bisphenol A 250/600 mouse/rat S.C injection Western [84]
3.4. <italic>In Vitro</italic> Evaluation of Estrogenic Activity of EDs Using the <italic>CaBP-9k</italic> Gene

In 2004, Fujimoto et al. identified estrogen-responsive genes in the rat pituitary GH3 cell line [98]. GH3 cells were initially characterized as ones that can synthesize growth hormone and prolactin (PRL) in response to E2 stimulation [99]. It was suggested that the GH3 cell line is a good candidate for assessing the in vitro estrogenicity of EDs since it is E2-sensitive and expresses functional ERs [98]. Recent studies have reported that EDs induce CaBP-9k expression in this cell line. OP, NP, and BPA induce a significant increase in CaBP-9k expression in GH3 cells in addition to augmenting growth hormone and PRL production and gene expression [100]. Moreover, activation of extracellular signal-regulated kinases (ERKs), protein kinases B (Akt), or G proteins by OP, NP and BPA has been observed in these cells [99,100]. Significant induction in CaBP-9k and PR gene expression was also observed after treatment with various concentrations of parabens [61]. In this study, the effects of parabens on the regulation of CaBP-9k expression were blocked in the presence of ICI 182,780, indicating that CaBP-9k is induced by EDs via the ER pathway in GH3 cell line.

Evaluation of the CaBP-9k gene as a biomarker for EDs activity in in vitro systems is summarized in Table 3. OP, isobutyl phenol, and ethyl- and isobutyl parabens produce the strongest induction of CaBP-9k expression at a concentration of 0.1 μM in GH3 cells, while NP and isopropyl- and butyl-parabens increase CaBP-9k gene expression at a concentration of 1 μM [100]. The concentration of BPA and methyl-and propyl-parabens required for inducing CaBP-9k gene expression is 10 μM [61]. The efficiency of CaBP-9k gene for EDs effect was sensitive than other genes, since pS2, ER and MUC1 were induced at 10 μM of NP in human breast MCF-7 cells, although the cell lines and other experimental conditions were different [54].

ijerph-09-00698-t003_Table 3

Expression of CaBP-9k on in vitro system under different EDs concentration.

Endocrine disruptors Minimum concentration (μM) Method Reference
Octyl phenol 0.1 q-PCR [62]
Ethyl paraben 0.1 q-PCR [101]
Isobutyl paraben 0.1 q-PCR [101]
Nonyl phenol 1 RT-PCR [100]
Isopropyl paraben 1 q-PCR [101]
Butyl paraben 1 q-PCR [101]
Bisphenol A 10 RT-PCR [100]
Methyl paraben 10 q-PCR [101]
Propyl paraben 10 q-PCR [101]

The sensitivity of the CaBP-9k gene for assessing estrogenic activity of EDs compared to other biomarkers is difficult to define because effect of intermediate concentrations (i.e., OP: 0.01–1 μM) of EDs have not been tested, particularly in in vivo models. However, the CaBP-9k gene has been evaluated as a biomarker for EDs activity by a number of in vivo and in vitro studies as described above. Taken together, data from these studies have demonstrated that the CaBP-9k gene is a sensitive and valuable biomarker for assessing the potential estrogenic activity of EDs.

 4. Conclusions

EDs are natural or synthetic chemicals with structures similar to those of endogenous hormones and have been shown to disrupt endocrine, nervous, and reproduction systems in animals and humans. There are growing concerns about health problems associated with exposure to EDs found in the environment. Chemicals that disrupt the endocrine system have been shown to have a high binding affinity to steroid hormone receptors, suggesting that exposure to EDs can seriously impact metabolism, development, reproduction, and behavior in mammals, including humans. Therefore, identification and characterization of EDs is urgent for predicting their detrimental effects. Efficient and accurate assays are required to measure EDs potency and to determine what chemicals can possibility be defined as EDs. However, methods for detecting the adverse effects of EDs are still limited. There are currently no sufficient standard biomarker systems or precise methods for evaluating the effects of EDs. Further research to determine the physiological concentration of various EDs (administered alone or in combination) necessary for disturbing biological systems and exerting adverse effects on human health is required. In this review, we discussed the properties of the CaBP-9k gene and its potential use as a biomarker for EDs activity. However, further studies to examine the accumulated, synergistic, and addictive effect of EDs using this biomarker are needed. In addition, identification of novel biomarkers that can determine the biologically and physiologically relevant concentrations of EDs is necessary.

Acknowledgments

This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ008323), Rural Development Administration, Republic of Korea.

 Conflict of Interest

The authors declare no conflict of interest.

 References Burlington H. Lindeman V.F. Effect of DDT on testes and secondary sex characters of white leghorn cockerels Proc. Soc. Exp. Biol. Med. 1950 74 48 51 15430386 Poliakov A.I. Kriger M.S. Dichlorodiphenyltrichloroethane in the treatment of males with trichomonal urethritis Vestn. Dermatol. Venerol. 1961 35 80 13867487 Schrager S. Potter B.E. Diethylstilbestrol exposure Am. Fam. Physician 2004 69 2395 2400 15168959 Giusti R.M. Iwamoto K. Hatch E.E. Diethylstilbestrol revisited: a review of the long-term health effects Ann. Intern. Med. 1995 122 778 788 7717601 Yamamoto M. Shirai M. Tamura A. Kobayashi T. Kohara S. Murakami M. Arishima K. Effects of maternal exposure to a low dose of diethylstilbestrol on sexual dimorphic nucleus volume and male reproductive system in rat offspring J. Toxicol. Sci. 2005 30 7 18 10.2131/jts.30.715800398 Bonde J.P. Storgaard L. How work-place conditions, environmental toxicants and lifestyle affect male reproductive function Int. J. Androl. 2002 25 262 268 10.1046/j.1365-2605.2002.00373.x12270022 Calafat A.M. Kuklenyik Z. Reidy J.A. Caudill S.P. Ekong J. Needham L.L. Urinary concentrations of bisphenol a and 4-nonylphenol in a human reference population Environ. Health Perspect. 2005 113 391 395 15811827 Korach K.S. Chae K. Gibson M. Curtis S. Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness Steroids 1991 56 263 270 10.1016/0039-128X(91)90045-W1877066 Kuiper G.G. Lemmen J.G. Carlsson B. Corton J.C. Safe S.H. van der Saag P.T. van der Burg B. Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta Endocrinology 1998 139 4252 4263 10.1210/en.139.10.42529751507 Dickerson S.M. Gore A.C. Estrogenic environmental endocrine-disrupting chemical effects on reproductive neuroendocrine function and dysfunction across the life cycle Rev. Endocr. Metab. Disord. 2007 8 143 159 10.1007/s11154-007-9048-y17674209 DeRosa C. Richter P. Pohl H. Jones D.E. Environmental exposures that affect the endocrine system: public health implications J. Toxicol. Environ. Health B Crit. Rev. 1998 1 3 26 10.1080/109374098095245419487091 Watanabe H. Suzuki A. Kobayashi M. Takahashi E. Itamoto M. Lubahn D.B. Handa H. Iguchi T. Analysis of temporal changes in the expression of estrogen-regulated genes in the uterus J. Mol. Endocrinol. 2003 30 347 358 10.1677/jme.0.030034712790804 Revankar C.M. Cimino D.F. Sklar L.A. Arterburn J.B. Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science 2005 307 1625 1630 10.1126/science.110694315705806 Matthews J.B. Fertuck K.C. Celius T. Huang Y.W. Fong C.J. Zacharewski T.R. Ability of structurally diverse natural products and synthetic chemicals to induce gene expression mediated by estrogen receptors from various species J. Steroid Biochem. Mol. Biol. 2002 82 181 194 10.1016/S0960-0760(02)00159-012477484 Liu H. Zhou Q. Wang Y. Zhang Q. Cai Z. Jiang G. E-waste recycling induced polybrominated diphenyl ethers, polychlorinated biphenyls, polychlorinated dibenzo-p-dioxins and dibenzo-furans pollution in the ambient environment Environ. Int. 2008 34 67 72 10.1016/j.envint.2007.07.00817959248 Wen S. Yang F. Li J.G. Gong Y. Zhang X.L. Hui Y. Wu Y.N. Zhao Y.F. Xu Y. Polychlorinated dibenzo-p-dioxin and dibenzofurans (PCDD/FS), polybrominated diphenyl ethers (PBDES), and polychlorinated biphenyls (PCBS) monitored by tree bark in an e-waste recycling area Chemosphere 2009 74 981 987 10.1016/j.chemosphere.2008.10.00219118860 Izzotti A. Kanitz S. D’Agostini F. Camoirano A. de Flora S. Formation of adducts by bisphenol A, an endocrine disruptor, in DNA in vitro and in liver and mammary tissue of mice Mutat. Res. 2009 679 28 32 10.1016/j.mrgentox.2009.07.01119660573 Stavrakakis C. Hequet V. Faur C. Andres Y. Le Cloirec P. Colin R. Biodegradation of endocrine disrupters: case of 17beta-estradiol and bisphenol a Environ. Technol. 2008 29 269 277 10.1080/0959333080209930418610788 Habert R. Muczynski V. Lehraiki A. Lambrot R. Lecureuil C. Levacher C. Coffigny H. Pairault C. Moison D. Frydman R. Adverse effects of endocrine disruptors on the foetal testis development: focus on the phthalates Folia Histochem. Cytobiol. 2009 47 S67 S74 10.2478/v10042-009-0056-5 Heudorf U. Mersch-Sundermann V. Angerer J. Phthalates: toxicology and exposure Int. J. Hyg. Environ. Health 2007 210 623 634 10.1016/j.ijheh.2007.07.01117889607 Han E.H. Jeong T.C. Jeong H.G. Methoxychlor suppresses the 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-inducible CYP1A1 expression in murine Hepa-1c1c7 cells J. Toxicol. Environ. Health A 2007 70 1304 1309 10.1080/1528739070142848117654248 Keum Y.S. Lee Y.H. Kim J.H. Metabolism of methoxychlor by Cunninghamella elegans ATCC36112 J. Agric. Food Chem. 2009 57 7931 7937 10.1021/jf902132j19691325 Schneider S. Kaufmann W. Buesen R. van Ravenzwaay B. Vinclozolin—the lack of a transgenerational effect after oral maternal exposure during organogenesis Reprod. Toxicol. 2008 25 352 360 10.1016/j.reprotox.2008.04.00118485663 Vilela M.L. Willingham E. Buckley J. Liu B.C. Agras K. Shiroyanagi Y. Baskin L.S. Endocrine disruptors and hypospadias: Role of genistein and the fungicide vinclozolin Urology 2007 70 618 621 10.1016/j.urology.2007.05.00417905137 Hagiwara H. Sugizaki T. Tsukamoto Y. Senoh E. Goto T. Ishihara Y. Effects of alkylphenols on bone metabolism in vivo and in vitro Toxicol. Lett. 2008 181 13 18 10.1016/j.toxlet.2008.06.86318621119 Hirose A. Koizumi M. Hasegawa R. Bisphenol. Alkylphenols Nihon Rinsho 2000 58 2428 2433 11187732 Hancock K.D. Coleman E.S. Tao Y.X. Morrison E.E. Braden T.D. Kemppainen B.W. Akingbemi B.T. Genistein decreases androgen biosynthesis in rat Leydig cells by interference with luteinizing hormone-dependent signaling Toxicol. Lett. 2009 184 169 175 10.1016/j.toxlet.2008.11.00519059320 Whitten P.L. Patisaul H.B. Young L.J. Neurobehavioral actions of coumestrol and related isoflavonoids in rodents Neurotoxicol. Teratol. 2002 24 47 54 10.1016/S0892-0362(01)00192-111836071 Cheek A.O. Brouwer T.H. Carroll S. Manning S. McLachlan J.A. Brouwer M. Experimental evaluation of vitellogenin as a predictive biomarker for reproductive disruption Environ. Health Perspect. 2001 109 681 690 11677175 Tian H. Ru S. Wang Z. Cai W. Wang W. Estrogenic effects of monocrotophos evaluated by vitellogenin mRNA and protein induction in male goldfish (Carassius auratus). Comp. Biochem. Physiol. C Toxical. Pharmacol. 2009 150 231 236 10.1016/j.cbpc.2009.04.014 Ebrahimi M. Vitellogenin assay by enzyme-linked immunosorbant assay as a biomarker of endocrine disruptor chemicals pollution Pak. J. Biol. Sci. 2007 10 3109 3114 10.3923/pjbs.2007.3109.311419090107 Henry T.B. McPherson J.T. Rogers E.D. Heah T.P. Hawkins S.A. Layton A.C. Sayler G.S. Changes in the relative expression pattern of multiple vitellogenin genes in adult male and larval zebrafish exposed to exogenous estrogens Comp. Biochem. Physiol. A Mol. Integr. Physiol. 2009 154 119 126 10.1016/j.cbpa.2009.05.00919464383 Jung J.H. Shim W.J. Addison R.F. Baek J.M. Han C.H. Protein and gene expression of VTG in response to 4-nonylphenol in rockfish (Sebastes schlegeli). Comp. Biochem. Physiol. C Toxical. Pharmacol. 2006 143 162 170 10.1016/j.cbpc.2006.01.009 Rey Vazquez G. Meijide F.J. Da Cuna R.H. Lo Nostro F.L. Piazza Y.G. Babay P.A. Trudeau V.L. Maggese M.C. Guerrero G.A. Exposure to waterborne 4-tert-octylphenol induces vitellogenin synthesis and disrupts testis morphology in the South American freshwater fish Cichlasoma dimerus (Teleostei, Perciformes). Comp. Biochem. Physiol. C Toxical. Pharmacol. 2009 150 298 306 10.1016/j.cbpc.2009.05.012 Andersson C. Katsiadaki I. Lundstedt-Enkel K. Orberg J. Effects of 17alpha-ethynylestradiol on EROD activity, spiggin and vitellogenin in three-spined stickleback (Gasterosteus aculeatus). Aquat. Toxicol. 2007 83 33 42 10.1016/j.aquatox.2007.03.00817445917 Puinean A.M. Rotchell J.M. Vitellogenin gene expression as a biomarker of endocrine disruption in the invertebrate, Mytilus edulis Mar. Environ. Res. 2006 62 S211 S214 10.1016/j.marenvres.2006.04.03516690117 Biales A.D. Bencic D.C. Lazorchak J.L. Lattier D.L. A quantitative real-time polymerase chain reaction method for the analysis of vitellogenin transcripts in model and nonmodel fish species Environ. Toxicol. Chem. 2007 26 2679 2686 10.1897/07-101.118020687 Owens W. Koeter H.B. The OECD program to validate the rat uterotrophic bioassay: An overview Environ. Health Perspect. 2003 111 1527 1529 10.1289/ehp.641312948895 Heikaus S. Winterhager E. Traub O. Grummer R. Responsiveness of endometrial genes Connexin26, Connexin43, C3 and clusterin to primary estrogen, selective estrogen receptor modulators, phyto- and xenoestrogens J. Mol. Endocrinol. 2002 29 239 249 10.1677/jme.0.029023912370124 Diel P. Schulz T. Smolnikar K. Strunck E. Vollmer G. Michna H. Ability of xeno- and phytoestrogens to modulate expression of estrogen-sensitive genes in rat uterus: estrogenicity profiles and uterotropic activity J. Steroid Biochem. Mol. Biol. 2000 73 1 10 10.1016/S0960-0760(00)00051-010822019 Hopert A.C. Beyer A. Frank K. Strunck E. Wunsche W. Vollmer G. Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model Environ. Health Perspect. 1998 106 581 586 10.1289/ehp.981065819721258 Sahu A. Lambris J.D. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity Immunol. Rev. 2001 180 35 48 10.1034/j.1600-065X.2001.1800103.x11414361 Li S.H. Huang H.L. Chen Y.H. Ovarian steroid-regulated synthesis and secretion of complement c3 and factor b in mouse endometrium during the natural estrous cycle and pregnancy period Biol. Reprod. 2002 66 322 332 10.1095/biolreprod66.2.32211804945 Babal P. Ruchko M. Campbell C.C. Gilmour S.P. Mitchell J.L. Olson J.W. Gillespie M.N. Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells J. Pharmacol. Exp. Ther. 2001 296 372 377 11160620 Dwivedi A. Gupta G. Keshri G. Dhar J.D. Changes in uterine ornithine decarboxylase activity and steroid receptor levels during decidualization in the rat induced by CDRI-85/287 Eur. J. Endocrinol. 1999 141 426 430 10.1530/eje.0.141042610526259 Teng C.S. Teng C.T. Studies on sex-organ development. Oestrogenic effect on ornithine decarboxylase activity in the differentiating Mullerian ducts and other organs of the chick embryo Biochem. J. 1978 176 143 149 728102 Kogo H. Johnson D.C. Dey S.K. Takeo S. A comparison of the effects of estradiol and 2- and 4-hydroxyestradiol on uterine ornithine decarboxylase activity in immature rats Jpn. J. Pharmacol. 1993 61 65 67 10.1254/jjp.61.658437370 Webster R.A. Zaloudek C.J. Inman B.C. Stewart P.J. Estrogen-like stimulation of uterine ornithine decarboxylase by cholera toxin Am. J. Physiol. 1984 246 E288 E291 6703055 Jakowlew S.B. Breathnach R. Jeltsch J.M. Masiakowski P. Chambon P. Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7 Nucleic Acids Res. 1984 12 2861 2878 10.1093/nar/12.6.28616324130 Zajchowski D.A. Sager R. Induction of estrogen-regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor Mol. Endocrinol. 1991 5 1613 1623 10.1210/mend-5-11-16131664044 Vivacqua A. Recchia A.G. Fasanella G. Gabriele S. Carpino A. Rago V. Di Gioia M.L. Leggio A. Bonofiglio D. Liguori A. The food contaminants bisphenol a and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells Endocrine 2003 22 275 284 10.1385/ENDO:22:3:275 Hewetson A. Chilton B.S. Molecular cloning and hormone-dependent expression of rabbit MUC1 in the cervix and uterus Biol. Reprod. 1997 57 468 477 10.1095/biolreprod57.2.4689241065 Spencer T.E. Bartol F.F. Bazer F.W. Johnson G.A. Joyce M.M. Identification and characterization of glycosylation-dependent cell adhesion molecule 1-like protein expression in the ovine uterus Biol. Reprod. 1999 60 241 250 10.1095/biolreprod60.2.2419915987 Ren L. Marquardt M.A. Lech J.J. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7 Chem. Biol. Interact. 1997 104 55 64 10.1016/S0009-2797(97)03767-89158695 Gao P. Zhou G.Y. Guo L.L. Zhang Q.H. Zhen J.H. Fang A.J. Lin X.Y. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter Cancer Lett. 2007 256 81 89 10.1016/j.canlet.2007.06.00517637500 Bagchi I.C. Cheon Y.P. Li Q. Bagchi M.K. Progesterone receptor-regulated gene networks in implantation Front. Biosci. 2003 8 S852 S861 10.2741/114812957875 Beyer C. Damm N. Brito V. Kuppers E. Developmental expression of progesterone receptor isoforms in the mouse midbrain Neuroreport 2002 13 877 880 10.1097/00001756-200205070-0002811997705 Sauter C.N. McDermid R.L. Weinberg A.L. Greco T.L. Xu X. Murdoch F.E. Fritsch M.K. Differentiation of murine embryonic stem cells induces progesterone receptor gene expression Exp. Cell Res. 2005 311 251 264 10.1016/j.yexcr.2005.09.00516223481 Lee Y.J. Gorski J. Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy Proc. Natl. Acad. Sci. USA 1996 93 15180 15184 10.1073/pnas.93.26.151808986784 Harper N. Wang X. Liu H. Safe S. Inhibition of estrogen-induced progesterone receptor in MCF-7 human breast cancer cells by aryl hydrocarbon (Ah) receptor agonists Mol. Cell. Endocrinol. 1994 104 47 55 10.1016/0303-7207(94)90050-77821706 Vo T.T. Jung E.M. Choi K.C. Yu F.H. Jeung E.B. Estrogen receptor alpha is involved in the induction of Calbindin-D9k and progesterone receptor by parabens in GH3 cells: A biomarker gene for screening xenoestrogens Steroids 2011 76 675 681 10.1016/j.steroids.2011.03.00621473877 Kim Y.R. Jung E.M. Choi K.C. Jeung E.B. Synergistic effects of octylphenol and isobutyl paraben on the expression of calbindin-D9k in GH3 rat pituitary cells Int. J. Mol. Med. 2011 29 294 302 22076563 Schafer B.W. Heizmann C.W. The s100 family of ef-hand calcium-binding proteins: Functions and pathology Trends Biochem. Sci. 1996 21 134 140 8701470 Santamaria-Kisiel L. Rintala-Dempsey A.C. Shaw G.S. Calcium-dependent and -independent interactions of the s100 protein family Biochem. J. 2006 396 201 214 10.1042/BJ2006019516683912 Jeung E.B. Krisinger J. Dann J.L. Leung P.C. Molecular cloning of the full-length cDNA encoding the human calbindin-D9k FEBS Lett. 1992 307 224 228 10.1016/0014-5793(92)80772-91379540 Jeung E.B. Leung P.C. Krisinger J. The human calbindin-D9k gene. Complete structure and implications on steroid hormone regulation J. Mol. Biol. 1994 235 1231 1238 10.1006/jmbi.1994.1076 Johansson C. Brodin P. Grundstrom T. Forsen S. Drakenberg T. Mutation of the pseudo-EF-hand of calbindin-D9k into a normal EF-hand. Biophysical studies Eur. J. Biochem. 1991 202 1283 1290 10.1111/j.1432-1033.1991.tb16501.x Choi K.C. Jeung E.B. The biomarker and endocrine disruptors in mammals J. Reprod. Dev. 2003 49 337 345 10.1262/jrd.49.33714967909 Christakos S. Gabrielides C. Rhoten W.B. Vitamin D-dependent calcium binding proteins: Chemistry, distribution, functional considerations, and molecular biology Endocr. Rev. 1989 10 3 26 10.1210/edrv-10-1-32666110 Choi K.C. Jeung E.B. Molecular mechanism of regulation of the calcium-binding protein calbindin-d9k, and its physiological role(s) in mammals: A review of current research J. Cell. Mol. Med. 2008 12 409 420 10.1111/j.1582-4934.2007.00209.x18182065 Darwish H.M. DeLuca H.F. Identification of a 1,25-dihydroxyvitamin D3-response element in the 5'-flanking region of the rat calbindin-D9k gene Proc. Natl. Acad. Sci. USA 1992 89 603 607 10.1073/pnas.89.2.6031309950 Mensenkamp A.R. Hoenderop J.G. Bindels R.J. Recent advances in renal tubular calcium reabsorption Curr. Opin. Nephrol. Hypertens. 2006 15 524 529 10.1097/01.mnh.0000242179.38739.fb16914966 Shamley D.R. Opperman L.A. Buffenstein R. Ross F.P. Ontogeny of calbindin-D28k and calbindin-D9k in the mouse kidney, duodenum, cerebellum and placenta Development 1992 116 491 496 1286620 Colnot S. Romagnolo B. Lambert M. Cluzeaud F. Porteu A. Vandewalle A. Thomasset M. Kahn A. Perret C. Intestinal expression of the calbindin-d9k gene in transgenic mice. Requirement for a CDx2-binding site in a distal activator region J. Biol. Chem. 1998 273 31939 31946 10.1074/jbc.273.48.319399822664 Barley N.F. Prathalingam S.R. Zhi P. Legon S. Howard A. Walters J.R. Factors involved in the duodenal expression of the human calbindin-D9k gene Biochem. J. 1999 341 491 500 10.1042/0264-6021:341049110417310 Peng J.B. Chen X.Z. Berger U.V. Vassilev P.M. Brown E.M. Hediger M.A. A rat kidney-specific calcium transporter in the distal nephron J. Biol. Chem. 2000 275 28186 28194 10875938 Lee G.S. Jung E.M. Choi K.C. Oh G.T. Jeung E.B. Compensatory induction of the TRPV6 channel in a calbindin-D9k knockout mouse: Its regulation by 1,25-hydroxyvitamin D3 J. Cell. Biochem. 2009 108 1175 1183 10.1002/jcb.2234719777446 Krisinger J. Dann J.L. Applegarth O. Currie W.D. Jeung E.B. Staun M. Leung P.C. Calbindin-D9k gene expression during the perinatal period in the rat: Correlation to estrogen receptor expression in uterus Mol. Cell. Endocrinol. 1993 97 61 69 10.1016/0303-7207(93)90211-28143906 Krisinger J. Dann J.L. Currie W.D. Jeung E.B. Leung P.C. Calbindin-D9k mRNA is tightly regulated during the estrous cycle in the rat uterus Mol. Cell. Endocrinol. 1992 86 119 123 10.1016/0303-7207(92)90182-61511778 L'Horset F. Blin C. Colnot S. Lambert M. Thomasset M. Perret C. Calbindin-D9k gene expression in the uterus: Study of the two messenger ribonucleic acid species and analysis of an imperfect estrogen-responsive element Endocrinology 1994 134 11 18 10.1210/en.134.1.117506202 Darwish H. Krisinger J. Furlow J.D. Smith C. Murdoch F.E. DeLuca H.F. An estrogen-responsive element mediates the transcriptional regulation of calbindin-D9k gene in rat uterus J. Biol. Chem. 1991 266 551 558 1985915 Lee K.Y. Oh G.T. Kang J.H. Shin S.M. Heo B.E. Yun Y.W. Paik S.G. Krisinger J. Leung P.C. Jeung E.B. Transcriptional regulation of the mouse calbindin-D9k gene by the ovarian sex hormone Mol. Cells 2003 16 48 53 14503844 Hong E.J. Choi K.C. Jeung E.B. Induction of calbindin-D9k messenger RNA and protein by maternal exposure to alkylphenols during late pregnancy in maternal and neonatal uteri of rats Biol. Reprod. 2004 71 669 675 10.1095/biolreprod.103.02614615070829 Dang V.H. Choi K.C. Hyun S.H. Jeung E.B. Induction of uterine calbindin-D9k through an estrogen receptor-dependent pathway following single injection with xenobiotic agents in immature rats J. Toxicol. Environ. Health A 2007 70 171 182 10.1080/1528739060075525717365578 Tatsumi K. Higuchi T. Fujiwara H. Nakayama T. Itoh K. Mori T. Fujii S. Fujita J. Expression of calcium binding protein D9k messenger RNA in the mouse uterine endometrium during implantation Mol. Hum. Reprod. 1999 5 153 161 10.1093/molehr/5.2.15310065871 Nie G.Y. Li Y. Wang J. Minoura H. Findlay J.K. Salamonsen L.A. Complex regulation of calcium-binding protein D9k (calbindin-D9k) in the mouse uterus during early pregnancy and at the site of embryo implantation Biol. Reprod. 2000 62 27 36 10.1095/biolreprod62.1.2710611064 An B.S. Choi K.C. Kang S.K. Lee G.S. Hong E.J. Hwang W.S. Jeung E.B. Mouse calbindin-D9k gene expression in the uterus during late pregnancy and lactation Mol. Cell. Endocrinol. 2003 205 79 88 10.1016/S0303-7207(03)00203-X12890569 An B.S. Choi K.C. Kang S.K. Hwang W.S. Jeung E.B. Novel calbindin-D9k protein as a useful biomarker for environmental estrogenic compounds in the uterus of immature rats Reprod. Toxicol. 2003 17 311 319 10.1016/S0890-6238(03)00003-012759100 An B.S. Kang S.K. Shin J.H. Jeung E.B. Stimulation of calbindin-D9k mRNA expression in the rat uterus by octyl-phenol, nonylphenol and bisphenol Mol. Cell. Endocrinol. 2002 191 177 186 10.1016/S0303-7207(02)00042-412062901 Dang V.H. Choi K.C. Hyun S.H. Jeung E.B. Analysis of gene expression profiles in the offspring of rats following maternal exposure to xenoestrogens Reprod. Toxicol. 2007 23 42 54 10.1016/j.reprotox.2006.08.01017011747 Dang V.H. Choi K.C. Jeung E.B. Tetrabromodiphenyl ether (BDE 47) evokes estrogenicity and calbindin-D9k expression through an estrogen receptor-mediated pathway in the uterus of immature rats Toxicol. Sci. 2007 97 504 511 10.1093/toxsci/kfm05117361017 Hong E.J. Ji Y.K. Choi K.C. Manabe N. Jeung E.B. Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of calbindin-D9k J. Reprod. Dev. 2005 51 253 263 10.1262/jrd.1607515883486 Lee G.S. Choi K.C. Kim H.J. Jeung E.B. Effect of genistein as a selective estrogen receptor beta agonist on the expression of calbindin-d9k in the uterus of immature rats Toxicol. Sci. 2004 82 451 457 10.1093/toxsci/kfh29615456916 Vo T.T. Jeung E.B. An evaluation of estrogenic activity of parabens using uterine calbindin-D9k gene in an immature rat model Toxicol. Sci. 2009 112 68 77 10.1093/toxsci/kfp17619654335 Lee G.S. Kim H.J. Jung Y.W. Choi K.C. Jeung E.B. Estrogen receptor alpha pathway is involved in the regulation of calbindin-D9k in the uterus of immature rats Toxicol. Sci. 2005 84 270 277 10.1093/toxsci/kfi07215635152 Jung E.M. An B.S. Choi K.C. Jeung E.B. Potential estrogenic activity of triclosan in the uterus of immature rats and rat pituitary GH3 cells Toxicol. Lett. 2012 208 142 148 10.1016/j.toxlet.2011.10.01722062131 Shin J.H. Moon H.J. Kang I.H. Kim T.S. Lee S.J. Oh J.Y. Lee Y.J. Hong E.J. Jeung E.B. Han S.Y. Calbindin-D9k mRNA expression in the rat uterus following exposure to methoxychlor: A comparison of oral and subcutaneous exposure J. Reprod. Dev. 2007 53 179 188 10.1262/jrd.1805417077578 Fujimoto N. Igarashi K. Kanno J. Inoue T. Identification of estrogen-responsive genes in the GH3 cell line by cDNA microarray analysis J. Steroid Biochem. Mol. Biol. 2004 91 121 129 10.1016/j.jsbmb.2004.02.00615276619 Dang V.H. Choi K.C. Jeung E.B. Estrogen receptors are involved in xenoestrogen induction of growth hormone in the rat pituitary gland J. Reprod. Dev. 2009 55 206 213 10.1262/jrd.2014719145065 Dang V.H. Nguyen T.H. Choi K.C. Jeung E.B. A calcium-binding protein, calbindin-D9k, is regulated through an estrogen-receptor mediated mechanism following xenoestrogen exposure in the GH3 cell line Toxicol. Sci. 2007 98 408 415 10.1093/toxsci/kfm12017504770 Yang H. Nguyen T.T. An B.S. Choi K.C. Jeung E.B. Synergistic effects of parabens on the induction of calbindin-D9k gene expression act via a progesterone receptor-mediated pathway in GH3 cells Hum. Exp. Toxicol. 2011 10.1177/0960327111422402